| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.3 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |